Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 3, 2008, Pages 589-594

  Larsen, A R ^a   Skov, R L ^a   Jarlier, V ^b   Henriksen, A S ^c  

^a STATENS SERUM INSTITUT   (Denmark)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c LEO PHARMA A S   (Denmark)

Author keywords

Clonal genotypes; Impetigo clone; Skin infections

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; ENTEROTOXIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COMMUNICABLE DISEASE; FRANCE; IRELAND; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; UNITED KINGDOM;

COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FRANCE; FUSIDIC ACID; GREAT BRITAIN; HUMANS; IRELAND; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 40049087996     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm532     Document Type: Article

References (36)

1. Sadick NS. Current aspects of bacterial infections of the skin. Dermatol Clin 1997; 15: 341-9.
2. Stulberg DL, Penrod MA, Blatny RA. Common bacterial skin infections. Am Fam Physician 2002; 66: 119-24.
3. Denton M, O'Connell B, Bernard P et al. The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. J Antimicrob Chemother 2008; 61: 586-8.
4. Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol 1998; 139 Suppl 53: 37-40.
5. Tveten Y, Jenkins A, Kristiansen BE. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. J Antimicrob Chemother 2002; 50: 873-6.
6. Osterlund A, Eden T, Olsson-Liljequist B et al. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid. Scand J Infect Dis 2002; 34: 729-34.
7. O'Neill AJ, Larsen AR, Henriksen AS et al. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. Antimicrob Agents Chemother 2004; 48: 3594-7.
8. Osterlund A, Kahlmeter G, Haeggman S et al. Staphylococcus aureus resistant to fusidic acid among Swedish children: A follow-up study. Scand J Infect Dis 2006; 38: 334.
9. Larsen A, Bocher S, Stegger M et al. Epidemiology of the European community associated methicillin-resistant Staphylococcus aureus (CC80-MRSA-IV) in Denmark 1993-2004. J Clin Microbiol 2008; 46: 62-8.
10. Witte W, Braulke C, Cuny C et al. Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 2005; 24: 1-5.
11. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus-aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.
12. Dufour P, Gillet Y, Bes M et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35: 819-24.
13. Mee-Marquet N, Blanchard M, Domelier AS et al. Virulence and antibiotic susceptibility of Staphylococcus aureus strains isolated from various origins. Pathol Biol (Paris) 2004; 52: 579-83.
14. Denton M, O'Connell B, Jamieson L et al. Susceptibility of Staphylococcus aureus isolates to antibiotics used in dermatology. Studies in patients with skin and soft tissue infections and in nasal carriers attending general practices in the U.K. and in Ireland. J Eur Acad Dermatol Venereol 2005; 19: Poster 01-42 (Fourteenth Congress of the European Academy of Dermatology and Venereology, London UK).
15. Jarlier V, Bernard P, Menday AP et al. The EPISA study: An epidemiological study in out patients with skin and soft tissue infection (SSTI) in France. Clin Microbiol Infect 2006; 12: Abstract P900 (Sixteenth European. Congress of Clinical Microbiology and Infectious. Diseases, Nice, France).
16. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - Sixth Edition: Approved Standard M7-A6. NCCLS Wayne, PA, USA, 2003.
17. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S13. NCCLS, Wayne, PA, USA, 2003.
18. Andrews JM. BSAC standardized disc susceptibility testing method (version 3). J Antimicrob Chemother 2004; 53: 713-28.
19. Murchan S, Kaufmann ME, Deplano A et al. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: A single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol 2003; 41: 1574-85.
20. Harmsen D, Claus H, Witte W et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41: 5442-8.
21. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15.
22. Ridom Bioinformatics. spa server. http://www.ridom.de (8 August 2007, date last accessed).
23. Multi Locus Sequence Typing home page. http://www.mlst.net/ (8 August 2007, date last accessed).
24. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton-Valentine leukocidin-producng Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29 1128-32.
25. Mehrotra M, Wang G, Johnson WM. Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. J Clin Microbiol 2000; 38: 1032-5.
26. Johnson AP, Aucken HM, Cavendish S et al. Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: Analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS). J Antimicrob Chemother 2001; 48: 143-4.
27. Johnson AP, Pearson A, Duckworth G. Surveillance and epidemiology of MRSA bacteraemia in the UK. J Antimicrob Chemother 2005; 56: 455-62.
28. O'Neill AJ, Larsen AR, Skov R et al. Characterization of the epidemic, European fusidic acid resistant, impetigo clone of Staphylococcus aureus. J Clin Microbiol 2006; 45: 1505-10.
29. Afset JE, Maeland JA. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: Indications of clonal spread of fusidic acid-resistant Staphylococcus aureus. Scand J Infect Dis 2003; 35: 84-9.
30. Mason BW, Howard AJ, Magee JT. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing. J Antimicrob Chemother 2003; 51: 1033-6.
31. Ravenscroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol 2000; 25: 327-30.
32. O'Neill AJ, Chopra I. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus. Mol Microbiol 2006; 59: 664-76.
33. Monecke S, Slickers P, Hotzel H et al. Microarray-based characterisation of a Panton-Valentine leukocidin-positive community-acquired strain of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2006; 12: 718-28.
34. Koning S, van Belkum A, Snijders S et al. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol 2003; 41: 3017-21.
35. Couppie P, Sainte-Marie D, Prevost G et al. Impetigo in French Guyana. A clinical, bacteriological, toxicological and sensitivity to antibiotics study. Ann Dermatol Venereol 1998; 125: 688-93.
36. Gravet, A, Couppie P, Meunier O et t al. Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases. J Clin Microbiol 2001; 39: 4349-56.